Literature DB >> 25832733

Tracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy.

Nazila Nouraee1, Seyed Javad Mowla, George A Calin.   

Abstract

In the past decades, cancer medicine studies have mainly focused on tumor cell biology as the main promoter of solid tumor progression. However, tumor biology does not explain the intertwinement and ambiguity of the tumors' territory. Recently, the approach of understanding cancer has shifted from investigating the biology of tumor cells to studying the microenvironment surrounding them. MicroRNAs (miRNAs), which play a role in exploiting indigenous stromal cells and are components that cooperate and produce a favorable microenvironment for progressive tumor formation, have been implicated in numerous processes essential for tumor initiation and growth. Understanding the mechanisms underlying interactions between tumor cells and their adjacent environment holds many promises for the future of cancer-targeted therapies. Herein, we provide a step-by-step account of miRNA involvement in tumor-microenvironment interactions as the micromediators of tumor cell and stroma communications. We also focus on the clinical challenges in using miRNAs tof overcome therapy resistance mechanisms and tumor heterogeneity bias in cancer therapy.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25832733      PMCID: PMC4659698          DOI: 10.1002/gcc.22244

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  153 in total

1.  MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.

Authors:  J-P Zhang; C Zeng; L Xu; J Gong; J-H Fang; S-M Zhuang
Journal:  Oncogene       Date:  2013-09-09       Impact factor: 9.867

2.  Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration.

Authors:  Keisuke Shimbo; Shigeru Miyaki; Hiroyuki Ishitobi; Yoshio Kato; Tadahiko Kubo; Shoji Shimose; Mitsuo Ochi
Journal:  Biochem Biophys Res Commun       Date:  2014-02-10       Impact factor: 3.575

Review 3.  What does physics have to do with cancer?

Authors:  Franziska Michor; Jan Liphardt; Mauro Ferrari; Jonathan Widom
Journal:  Nat Rev Cancer       Date:  2011-08-18       Impact factor: 60.716

Review 4.  Alterations of microRNAs contribute to colon carcinogenesis.

Authors:  Aaron J Schetter; Curtis C Harris
Journal:  Semin Oncol       Date:  2011-12       Impact factor: 4.929

Review 5.  Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage.

Authors:  Sergei I Grivennikov; Michael Karin
Journal:  Ann Rheum Dis       Date:  2011-03       Impact factor: 19.103

6.  Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation.

Authors:  Michael C Schmid; Judith A Varner
Journal:  J Oncol       Date:  2010-05-16       Impact factor: 4.375

Review 7.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

8.  miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.

Authors:  Andrea L Kasinski; Frank J Slack
Journal:  Cancer Res       Date:  2012-09-10       Impact factor: 12.701

9.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis.

Authors:  Weiying Zhou; Miranda Y Fong; Yongfen Min; George Somlo; Liang Liu; Melanie R Palomares; Yang Yu; Amy Chow; Sean Timothy Francis O'Connor; Andrew R Chin; Yun Yen; Yafan Wang; Eric G Marcusson; Peiguo Chu; Jun Wu; Xiwei Wu; Arthur Xuejun Li; Zhuo Li; Hanlin Gao; Xiubao Ren; Mark P Boldin; Pengnian Charles Lin; Shizhen Emily Wang
Journal:  Cancer Cell       Date:  2014-04-14       Impact factor: 31.743

10.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

View more
  5 in total

1.  A novel signaling role for miR-451 in esophageal tumor microenvironment and its contribution to tumor progression.

Authors:  S Khazaei; N Nouraee; A Moradi; S J Mowla
Journal:  Clin Transl Oncol       Date:  2016-11-28       Impact factor: 3.405

2.  Evolution of Cancer Stem-like Cells in Endocrine-Resistant Metastatic Breast Cancers Is Mediated by Stromal Microvesicles.

Authors:  Pasquale Sansone; Marjan Berishaj; Vinagolu K Rajasekhar; Claudio Ceccarelli; Qing Chang; Antonio Strillacci; Claudia Savini; Lauren Shapiro; Robert L Bowman; Chiara Mastroleo; Sabrina De Carolis; Laura Daly; Alberto Benito-Martin; Fabiana Perna; Nicola Fabbri; John H Healey; Enzo Spisni; Monica Cricca; David Lyden; Massimiliano Bonafé; Jacqueline Bromberg
Journal:  Cancer Res       Date:  2017-02-15       Impact factor: 12.701

3.  Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts.

Authors:  Zhen-Fei Wang; Da-Guang Ma; Zhe Zhu; Yong-Ping Mu; Yong-Yan Yang; Li Feng; Hao Yang; Jun-Qing Liang; Yong-Yan Liu; Li Liu; Hai-Wen Lu
Journal:  World J Gastroenterol       Date:  2017-12-28       Impact factor: 5.742

4.  Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma.

Authors:  Hamideh Monfared; Yavar Jahangard; Maryam Nikkhah; Javad Mirnajafi-Zadeh; Seyed Javad Mowla
Journal:  Front Oncol       Date:  2019-08-20       Impact factor: 6.244

5.  Aberrant Expression of Breast Development-Related MicroRNAs, miR-22, miR-132, and miR-212, in Breast Tumor Tissues.

Authors:  Zahra Damavandi; Safoora Torkashvand; Mohammad Vasei; Bahram M Soltani; Mahmood Tavallaei; Seyed Javad Mowla
Journal:  J Breast Cancer       Date:  2016-06-24       Impact factor: 3.588

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.